PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-165.00%
Negative net income growth while VET stands at 181.64%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
-102.63%
Negative yoy deferred tax while VET stands at 88.73%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-318.18%
Negative yoy working capital usage while VET is 225.62%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-23.40%
AR is negative yoy while VET is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-160.78%
Negative yoy usage while VET is 225.62%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
15.37%
Some yoy increase while VET is negative at -28.90%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-14.41%
Negative yoy CFO while VET is 31.89%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-20.53%
Negative yoy CapEx while VET is 71.01%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-378.62%
Negative yoy acquisition while VET stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
205.71%
We have some outflow growth while VET is negative at -97.71%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-66.05%
Both yoy lines negative, with VET at -711.88%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
115.49%
Debt repayment well below VET's 1201.04%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.